Abiomed
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Abiomed generated cash of $285,390,000, which is more than the previous year. Cash used in financing activities reached the amount of -$2,202,000 last year. Net change in cash is therefore -$99,892,000.
Cash Flow
| 2013 | 26.39M | -10.26M | -11.81M |
|---|---|---|---|
| 2014 | 23.46M | -22.27M | 9.63M |
| 2015 | 43.29M | -49.86M | 9.52M |
| 2016 | 76.79M | -57.71M | 7.16M |
| 2017 | 115.11M | -126.33M | 3.86M |
| 2018 | 192.54M | -180.76M | -9.13M |
| 2019 | 252.19M | -116.45M | -55.77M |
| 2020 | 314.92M | -125.45M | -117.71M |
| 2021 | 274.57M | -223.34M | -8.06M |
| 2022 | 285.39M | -380.99M | -2.20M |
ABMD Cash Flow Statement (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 232.71M | 192.34M | 121.02M | 42.97M | 39.04M | 48.23M | 22.40M | 20.91M | 9.45M | 5.99M |
Operating activities | ||||||||||
Net income | 136.50M | 225.52M | 203.00M | 259.01M | 112.17M | 52.11M | 38.14M | 113.68M | 7.35M | 15.01M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 28.08M | 24.09M | 20.43M | 14.12M | 11.00M | 6.20M | 3.27M | 2.77M | 2.50M | 2.72M |
Stock-based compensation expense | 52.72M | 47.00M | 39.78M | 0 | 40.35M | 32.86M | 29.05M | 16.52M | 11.21M | 9.50M |
| Deferred income tax benefit | 52.72M | 47.00M | 39.78M | 0 | 40.35M | 32.86M | 29.05M | 16.52M | 11.21M | 9.50M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 5.33M | -12.05M | 5.55M | -22.02M | -15.28M | -11.55M | -10.93M | -7.97M | -1.31M | -2.58M |
Inventories | -29.32M | 2.53M | -13.23M | -37.18M | -15.68M | -12.28M | -11.47M | -6.96M | -622K | -5.31M |
Accounts payable | 641K | 2.62M | 2.58M | 7.97M | 4.41M | 7.56M | -2.64M | 3.37M | -54K | 1.18M |
Cash generated by operating activities | 285.39M | 274.57M | 314.92M | 252.19M | 192.54M | 115.11M | 76.79M | 43.29M | 23.46M | 26.39M |
Investing activities | ||||||||||
Purchases Of Investments | -805.91M | -582.30M | -632.23M | -404.33M | -331.80M | -281.4M | -261.72M | -100.50M | -87.77M | -49.42M |
Investments In Property Plant And Equipment | -35.76M | -53.38M | -44.00M | -44.00M | -55.86M | -50.41M | -15.62M | -5.18M | -2.76M | -2.83M |
Acquisitions Net | -82.82M | -52.18M | 0 | 0 | 0 | 0 | 0 | -15.69M | 0 | 0 |
Cash generated by investing activities | -380.99M | -223.34M | -125.45M | -116.45M | -180.76M | -126.33M | -57.71M | -49.86M | -22.27M | -10.26M |
Financing activities | ||||||||||
Common Stock Issued | 7.23M | 5.47M | 5.10M | 3.05M | 2.39M | 1.72M | 1.13M | 795K | -257K | -257K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | -11.31M | -84.87M | 0 | 0 | 0 | 0 | 0 | -425K | -15.30M |
Repayments of term debt | 0 | 0 | 0 | 0 | -517K | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | -2.20M | -8.06M | -117.71M | -55.77M | -9.13M | 3.86M | 7.16M | 9.52M | 9.63M | -11.81M |
Net Change In Cash | -99.89M | 40.36M | 71.32M | 78.04M | 3.93M | -9.19M | 25.83M | 1.48M | 11.46M | 3.46M |
Cash at end of period | 132.81M | 232.71M | 192.34M | 121.02M | 42.97M | 39.04M | 48.23M | 22.40M | 20.91M | 9.45M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |